INTRODUCTION
Langerhans cell histiocytosis (LCH) is a disease of dysregulated proliferation of Langerhans cells with subsequent organ involvement. Congenital self-healing reticulohistiocytosis (CSHRH) is a congenital variant of LCH, which does not show systemic involvement 1 . Clinical presentation typically consists of multiple papules or nodules, which show spontaneous involution within a few months. Due to its poorly specific clinical features and self-limiting character, solitary CSHRH is much rarer and difficult to diagnose. Since it is prone to be confused with other dermatologic tumor conditions, dermatologists should have an understanding of the clinical and histologic findings. In Korea, just two cases of solitary CSHRH have been reported 2, 3 . Herein, we report on an additional case of solitary CSHRH.
CASE REPORT
A 29-day-old girl presented with a solitary skin colored papule with crust on her left sole since birth. She was delivered at term by vaginal delivery following a normal pregnancy to a primipara primigravida mother. Overall, she was healthy, without perinatal problems. There was no Ed-highlight-Please review. Family history. Physical examination revealed a domeshaped, skin colored papule measuring 7 mm, with crust, on her left sole (Fig. 1A) . However, no organomegaly or superficial palpable lymph nodes were observed. Clinical diagnoses, including hemangioma, juvenile xanthogranuloma, and congenital self-healing reticulohistiocytosis were made and skin biopsy was performed on the sole. Atrophic epidermis and effacement of rete ridges were observed ( Fig. 2A) . A dense infiltrate of histiocytic cells admixed with numerous eosinophils and some scattered lymphocytes were observed. No multinucleated giant cells were observed in our histologic section (Fig. 2B ). Histiocytes had a large, vesicular, and some kidney-shaped nuclei with prominent nucleoli. On immunohistiochemical staining with CD1a and S-100, the majority of tumor cells showed strong reactivity (Fig. 3) . Ultrastructural studies were not performed. Laboratory studies, including complete blood count, coagulation profile, serum protein electrophoresis, chemical battery, urinalysis, VDRL, congenital infection studies (TORCH), and chest radiography were normal. Two months later, the lesion had completely regressed, leaving a scar (Fig. 1B) . At 1 year after diagnosis, no recurrence or systemic involvement has been observed. Based upon clinical, histopathologic, and laboratory findings, a diagnosis of congenital self-healing reticulohistiocytosis was made. Differential diagnosis includes hemangioma, juvenile xanthogranuloma, Spitz nevi, mastocytoma, and histiocytic disorders. Those diseases can be differentiated by histopathologic findings. In cases of juvenile xanthogranuloma, histiocytes can be differentiated with immunohistochemical staining, such as S-100 protein and CD1a. Among histiocytic disorders, differentiation of indeterminate cell histiocytoma (ICH) from CSHRH is difficult. ICH is characterized by positive immunohistochemical staining for S-100 protein and CD1a, but can be differentiated from CSHRH by absence of Birbeck granules 13 . Electron microscopic examination of CSHRH reveals Birbeck granules and laminated dense bodies in 10 to 25% of histiocytes 14 .
DISCUSSION
In our case, we did not perform an electron microscopic examination, but made a diagnosis of CSHRH, since, ICH is much more rare than CSHRH, has tendency to occur in adults, and only a few cases have been reported as a solitary variant 7, 15 .
The pathogenesis of the self-limiting nature of CSHRH remains to be elucidated. Weiss et al. 16 have studied various dendritic cell markers in CSHRH. With immunohistochemistry, tumor cells showed positive staining for S-100 protein, CD1a, and HLA-DR. However, tumor cells showed negative staining for Langerin and CD68. They speculated that CSHRH should be comprised of activated mature LCs, because CD68 expression is lost and Langerin staining is decreased in the process of LCs and dendritic cell maturation 17, 18 . The authors explained the selfregressing character of CSHRH as the tumor cells of CSHRH eventually becoming apoptotic on terminal maturation, which is the natural course of LC activation 16 .
No treatment is required for CSHRH; however, clinical and laboratory monitoring is mandatory. 
